DM
PTLA
Deerfield Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,617,543
| Closed | -$90.8M | – | 106 |
|
|
2019
Q1 | $90.8M | Buy |
2,617,543
+940,129
| +56% | +$32.6M | 3.48% | 6 |
|
|
2018
Q4 | $32.7M | Sell |
1,677,414
-778,172
| -32% | -$15.2M | 1.31% | 26 |
|
|
2018
Q3 | $65.4M | Buy |
2,455,586
+1,008,953
| +70% | +$26.9M | 2.34% | 8 |
|
|
2018
Q2 | $54.6M | Buy |
+1,446,633
| New | +$54.6M | 1.92% | 13 |
|
|
2018
Q1 | – | Sell |
-298,545
| Closed | -$14.5M | – | 127 |
|
|
2017
Q4 | $14.5M | Hold |
298,545
| – | – | 0.57% | 55 |
|
|
2017
Q3 | $16.1M | Sell |
298,545
-120,455
| -29% | -$6.51M | 0.73% | 43 |
|
|
2017
Q2 | $23.5M | Sell |
419,000
-1,032,301
| -71% | -$58M | 1.26% | 24 |
|
|
2017
Q1 | $56.9M | Sell |
1,451,301
-3,203,146
| -69% | -$126M | 2.19% | 9 |
|
|
2016
Q4 | $104M | Sell |
4,654,447
-985,280
| -17% | -$22.1M | 4.3% | 4 |
|
|
2016
Q3 | $128M | Buy |
5,639,727
+1,966,000
| +54% | +$44.6M | 5.96% | 2 |
|
|
2016
Q2 | $86.7M | Buy |
3,673,727
+583,942
| +19% | +$13.8M | 3.41% | 4 |
|
|
2016
Q1 | $63M | Buy |
3,089,785
+2,406,036
| +352% | +$49.1M | 2.68% | 8 |
|
|
2015
Q4 | $35.2M | Buy |
683,749
+353,912
| +107% | +$18.2M | 1.43% | 17 |
|
|
2015
Q3 | $14.1M | Hold |
329,837
| – | – | 0.54% | 58 |
|
|
2015
Q2 | $15M | Sell |
329,837
-244,709
| -43% | -$11.1M | 0.5% | 60 |
|
|
2015
Q1 | $21.8M | Sell |
574,546
-81,013
| -12% | -$3.08M | 0.71% | 38 |
|
|
2014
Q4 | $18.6M | Buy |
655,559
+98,082
| +18% | +$2.78M | 0.67% | 39 |
|
|
2014
Q3 | $14.1M | Sell |
557,477
-27,371
| -5% | -$692K | 0.51% | 52 |
|
|
2014
Q2 | $17.1M | Sell |
584,848
-185,000
| -24% | -$5.4M | 0.69% | 44 |
|
|
2014
Q1 | $19.9M | Sell |
769,848
-55,827
| -7% | -$1.45M | 0.81% | 38 |
|
|
2013
Q4 | $21.3M | Buy |
825,675
+706,227
| +591% | +$18.2M | 1.1% | 32 |
|
|
2013
Q3 | $3.2M | Sell |
119,448
-407,962
| -77% | -$10.9M | 0.15% | 81 |
|
|
2013
Q2 | $13M | Buy |
+527,410
| New | +$13M | 0.61% | 53 |
|